Reported 1,871,892 shares, up 377,592 (25.3%) from the prior quarter.
Reported value 25.0%; share count 25.3% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-12-31 | 32053440 |
| 2026-03-31 | 74583360 |
| 2026-06-30 | 106170015 |
| 2026-09-30 | 132698424 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 1,871,892 | +377,592 (25.3%) | 5.89% | $132,698,424 | 2026-11-16 | |
| Q2 2026 | Added | 1,494,300 | +392,300 (35.6%) | 5.16% | $106,170,015 | 2026-08-14 | |
| Q1 2026 | Added | 1,102,000 | +330,000 (42.7%) | 3.17% | $74,583,360 | 2026-05-15 | |
| Q4 2025 | New | 772,000 | +772,000 (0.0%) | 1.45% | $32,053,440 | 2026-02-17 |
Who else reported the position
268 managers reported CG ONCOLOGY INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| RTW INVESTMENTS LP | Unchanged | 8,514,590 | 0 | 6.08% | $603,599,285 | 11 qtrs |
| T Rowe Price Investment Management Inc | Added | 6,726,945 | +110,046 | 0.34% | $476,874,000 | 4 qtrs |
| Decheng Capital LLC | Unchanged | 6,371,669 | 0 | 65.93% | $451,687,615 | 11 qtrs |
| BlackRock Inc | Added | 6,347,335 | +91,047 | < 0.01% | $449,962,578 | 9 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 4,917,082 | -407,669 | 0.06% | $348,571,943 | 11 qtrs |
| FMR LLC | Added | 4,594,462 | +432,969 | 0.01% | $325,701,402 | 11 qtrs |
| TCG Crossover Management LLC | Unchanged | 3,670,206 | 0 | 7.35% | $260,180,903 | 11 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 3,574,032 | +257,239 | < 0.01% | $253,363,128 | 3 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Added | 3,515,620 | +50,423 | 0.01% | $249,222,302 | 3 qtrs |
| STATE STREET CORPORATION | Reduced | 3,233,885 | -203,705 | < 0.01% | $229,250,108 | 11 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 1,871,892
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.